NCT02350400View on ClinicalTrials.gov

Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI).

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Colorectal Cancer Metastatic
Interventions
DEVICE

DEBIRI

DEBIRI TACE

Trial Locations (2)

169608

Singapore General Hospital, Singapore

169610

National Cancer Centre Singapore, Singapore

All Listed Sponsors
collaborator

Singhealth Foundation

OTHER_GOV

lead

Singapore General Hospital

OTHER

NCT02350400 - Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI). | Biotech Hunter | Biotech Hunter